 Accelerate Diagnostics NASDAQ:AXDX was upgraded by BidaskClub from a strong sell rating to a sell rating in a research report issued to clients and investors on Thursday, BidAskClub reports. A number of other equities analysts also recently issued reports on AXDX. Zacks Investment Research downgraded shares of Accelerate Diagnostics from a buy rating to a ... 